A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas(with Possible Late Autologous Stem Cell Transplant) for Patients with Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups (A BMT Study)

Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis

Z Al-Mansour;H Li;JR Cook;LS Constine;S Couban;DA Stewart;TC Shea;P Porcu;JN Winter;BS Kahl;S Smith;DC Marcellus;KP Barton;GM Mills;M LeBlanc;L Rimsza;SJ Forman;JP Leonard;RI Fisher;JW Friedberg;PJ Stiff Leukemia and Lymphoma Aug;60(8):1934-1941; Jan 10:1-8. doi: 10.1080/10428194.2018.1563691. [Epub ahead of print]

PMid: PMID30628511 | PMC number: PMC6620162

Survival by Hispanic Ethnicity among Cancer Patients Participating in SWOG Clinical Trials

M Chavez-MacGregor;J Unger;A Moseley;S Ramsey;DL Hershman Cancer Apr 15;124(8):1760-1769; Jan 25 [Epub ahead of print]

PMid: PMID29370458 | PMC number: PMC5963502

Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: Subset analysis of randomized trial intergroup S9704

SD Puvvada;P Stiff;M Leblanc;JR Cook;S Couban;JP Leonard;B Kahl;D Marcellus;T Shea;JN Winter;H Li;LM Rimsza;JW Friedberg;S Smith British Journal of Haematology Sep;174(5):686-691; 2016 Apr 13 [Epub ahead of print]

PMid: PMID27072903 | PMC number: PMC5125530

Beyond RCHOP: A blueprint for diffuse large B-cell lymphoma research

GS Nowakowski;KA Blum;JW Friedberg;L Baizer;R Little;D Maloney;LH Sehn;ME Williams;W Wilson;JP Leonard;SM Smith Journal of the National Cancer Institute Dec 16;108(12). pii: djw257. Print 2016 Dec.

PMid: PMID27986884 | PMC number: pending

Autologous transplantation as consolidation for high risk aggressive t-cell non-Hodgkin’s lymphoma: a SWOG S9704 intergroup trial subgroup analysis

PJ Stiff;H Li;JR Cook;LS Constine;S Couban;DA Stewart;TC Shea;P Porcu;JN Winter;BS Kahl;SM Smith;D Marcellus;KP Barton;GM Mills;M LeBlanc;LM Rimsza;SJ Forman;JP Leonard;RI Fisher;JW Friedberg Blood 128:4651; American Society of Hematology Annual Meeting (December 3-6, 2016, San Hematology Annual Meeting (December 3-6, 2016, SanDiego, CA), poster

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

H Gustafson (Tardif);S Yao;B Goldman;K Lee;C Spier;M LeBlanc;L Rimsza;JR Cernan;TM Habermann;BK Link;MJ Mauer;SL Slager;D Persky;T Miller;RI Fisher;C Ambrosone;M Briehl American Journal of Hematology 89(6):639-645;

PMid: PMID24633940 | PMC number: PMC4137041

Clinical significance of MYC protein expression and/or high grade morphology in non-Burkitt, diffuse aggressive B-cell non-Hodgkin lymphomas: a SWOG S9704 correlative study

JR Cook;B Goldman;RR Tubbs;L Rimsza;M LeBlanc;P Stiff;RI Fisher American Journal of Surgical Pathology 38(4):494-501;

PMid: PMID24625415 | PMC number: PMC3955880

The role of myeloablation for lymphoma

PJ Stiff;JM Unger;RI Fisher New England Journal of Medicine 370(6):575-576

PMid: PMID24499218 | PMC number: n/a - correspondence not within the scope of Public Access Policy

Double hit lymphoma and double positive lymphoma: subset analyses of MYC positive patients of SWOG S9704

S Puvvada;P Stiff;M Leblanc;JR Cook;BS Kahl;H Li;L Rimsza;JW Friedberg;SM Smith Blood 124(21):1710; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;

Autologous transplant as consolidation for aggressive non-hodgkin's lymphoma

P Stiff;J Unger;J Cook;L Constine;S Couban;D Stewart;T Shea;P Porcu;J Winter;BS Kahl;T Miller;R Tubbs;D Marcellus;J Friedberg;K Barton;G Mills;M Leblanc;L Rimsza;S Forman;RI Fisher New England Journal of Medicine, 369(18):1681-1690;

PMid: PMID24171516 | PMC number: PMC3985418

MYC protein expression, but not high grade morphology, is associated with poor outcome in non-Burkitt diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study

JR Cook;B Goldman;RR Tubbs;L Rimsza;M LeBlanc;P Stiff;RI Fisher Blood 120(21):abst.543; American Society of Hematology Annual Meeting, oral;

Randomized phase III US/Canadian intergroup trial (SWOG S9704) comparing CHOP+/- R x 8 vs. CHOP +/- R x 6 followed by high dose therapy and autotransplant for patients with diffuse aggressive non-Hodgkin's lymphoma (NHL) in the high-intermediate (H-Int) or high IPI risk groups

P Stiff;J Unger;J Cook;L Constine;S Couban;T Shea;JN Winter;TP Miller;RR Tubbs;D Marcellus;J Friedberg;K Barton;G Mills;M LeBlanc;L Rimsza;S Forman;RI Fisher Journal of Clinical Oncology 29:(suppl; abstr 8001); ASCO 2011 Annual Meeting, oral presentation

Diffuse large B-cell lymphomas with high grade morphologic features and/or MYC translocations lack distinctive clinicopathologic features at presentation: a SWOG S9704 study

J Cook;R Tubbs;L Rimsza;P Stiff;M LeBlanc;R Fisher;B Goldman United States and Canadian Academy of Pathology 99th Annual Meeting, abst #1308 (3/20-26, 2010, Wash DC); poster